Table 2.
Mean (Standard Deviation) Symptoms and Function by Age.
| Scale (Range) | Young (Age < 55) N=109 to 123 |
Old (Age ≥ 55) N=51 to 61 |
T Value (df)* |
p * |
|---|---|---|---|---|
| FIBSER Frequency (0 – 6) | 1.99 (2.20) n = 101 |
1.81 (2.09) n = 52 |
−0.50 (107.9) |
0.62 |
| FIBSER Intensity (0 – 6) | 1.78 (1.76) n = 102 |
1.60 (1.74) n = 52 |
−0.61 (106.8) |
0.54 |
| FIBSER Burden (0 – 6) | 1.21 (1.63) n = 102 |
1.28 (1.61) n = 52 |
0.26 (109.5) |
0.79 |
| PHQ-9 (0-27) | 10.3 (7.2) n = 112 |
8.9 (7.67) n = 55 |
−1.19 (102.0) |
0.23 |
| QIDS (0-27) | 11.5 (5.9) n = 110 |
8.8 (5.6) n = 55 |
−2.82 (113.2) |
<0.01 |
| ASRM (0 -20) | 3.4 (3.4) n = 111 |
3.0 (3.4) n = 55 |
−0.60 (106.8) |
0.55 |
| WSAS (0-40) | 18.4 (13.0) n = 109 |
17.0 (12.4) n = 51 |
−0.70 (101.9) |
0.49 |
| SCQ (0 – 45) | 2.9 (3.7) n = 123 |
4.7 (4.6) n = 61 |
2.76 (99.4) |
<0.01 |
*
test statistic, degrees of freedom (df) and two-sided p-value obtained from two-sample t-tests (using Satterthwaite method)
PHQ-9: Patient Health Questionnaire; QIDS: Quick Inventory of Depressive Symptomatology; ASRM: Altman Self-Rating Mania Scale; WSAS: Work and Social Adjustment Scale; SCQ: Self-Administered Comorbidity Questionnaire; FIBSER: Frequency and Intensity of Burden of Side Effects Rating.